TY  - GEN
AU  - Dudley,Mark E
AU  - Yang,James C
AU  - Sherry,Richard
AU  - Hughes,Marybeth S
AU  - Royal,Richard
AU  - Kammula,Udai
AU  - Robbins,Paul F
AU  - Huang,JianPing
AU  - Citrin,Deborah E
AU  - Leitman,Susan F
AU  - Wunderlich,John
AU  - Restifo,Nicholas P
AU  - Thomasian,Armen
AU  - Downey,Stephanie G
AU  - Smith,Franz O
AU  - Klapper,Jacob
AU  - Morton,Kathleen
AU  - Laurencot,Carolyn
AU  - White,Donald E
AU  - Rosenberg,Steven A
TI  - Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens
SN  - 1527-7755
PY  - 2008///1204
KW  - Adolescent
KW  - Adoptive Transfer
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Cells, Cultured
KW  - Chemotherapy, Adjuvant
KW  - Child
KW  - Cyclophosphamide
KW  - administration & dosage
KW  - Female
KW  - Humans
KW  - Interleukin-15
KW  - blood
KW  - Interleukin-2
KW  - Interleukin-7
KW  - Kaplan-Meier Estimate
KW  - Lymphocyte Depletion
KW  - Lymphocytes, Tumor-Infiltrating
KW  - immunology
KW  - Male
KW  - Melanoma
KW  - drug therapy
KW  - Middle Aged
KW  - Myeloablative Agonists
KW  - Neoadjuvant Therapy
KW  - Neoplasm Metastasis
KW  - Pilot Projects
KW  - Radiotherapy Dosage
KW  - Radiotherapy, Adjuvant
KW  - Time Factors
KW  - Treatment Outcome
KW  - Vidarabine
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1200/JCO.2008.16.5449
ER  -